Bjork Elisabeth
SEC insider (Form 3/4/5 filer). CIK 0001810406. Director at Pharvaris N.V. (PHVS) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in LEXINGTON, MA.
Companies Bjork Elisabeth has filed insider reports for
- Pharvaris N.V. (PHVS): Director
- ROCKET PHARMACEUTICALS, INC. (RCKT): Director
Bjork Elisabeth
CIK: 0001810406
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 17, 2026PHVS
Pharvaris N.V.
ExerciseDirect17.5K shares at avg. $18.14$317K - Sep 17, 2026PHVS
Pharvaris N.V.
SaleDirect52.5K shares at avg. $37.89$2.0M - Sep 17, 2026PHVS
Pharvaris N.V.
ExerciseDirect35K shares at avg. $14.39$504K - May 20, 2026PHVS
Pharvaris N.V.
ExerciseDirect10K shares at avg. $8.05$81K - May 20, 2026PHVS
Pharvaris N.V.
SaleDirect10K shares at avg. $29.32$293K - Jan 2, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
PurchaseDirect10K shares at avg. $3.44$34K - Aug 27, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
PurchaseDirect10K shares at avg. $3.41$34K - Jun 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect30K shares- - Sep 26, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
607 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 |  PHVS Pharvaris N.V. | Exercise | 17,500 | $18.14 | $317,450 | Direct |
| Sep 17, 2026 | PHVS Pharvaris N.V. | Sale | 52,500 | $37.89 | $1,989,409 | Direct |
| Sep 17, 2026 | PHVS Pharvaris N.V. | Exercise | 35,000 | $14.39 | $503,650 | Direct |
| May 20, 2026 | PHVS Pharvaris N.V. | Exercise | 10,000 | $8.05 | $80,500 | Direct |
| May 20, 2026 | PHVS Pharvaris N.V. | Sale | 10,000 | $29.32 | $293,166 | Direct |
| Jan 2, 2026 |  RCKT ROCKET PHARMACEUTICALS, INC. | Purchase | 10,000 | $3.44 | $34,400 | Direct |
| Aug 27, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Purchase | 10,000 | $3.41 | $34,100 | Direct |
| Jun 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award | 30,000 | - | - | Direct |
| Sep 26, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 607 | - | - | Direct |
1-9 of 9 transactions